CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin-Reference-Cited by-同舟云学术

CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin

Published:2014-12-11 Issue:1 Volume:21 Page:146-156
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Guerzoni Clara,Fiori Valentina,Terracciano Mario,Manara Maria Cristina,Moricoli Diego,Pasello Michela,Sciandra Marika,Nicoletti Giordano,Gellini Mara,Dominici Sabrina,Chiodoni Claudia,Fornasari Pier Maria,Lollini Pier-Luigi,Colombo Mario P.,Picci Piero,Cianfriglia Maurizio,Magnani Mauro,Scotlandi Katia

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1‐targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape;Journal of Cell Communication and Signaling;2024-08-02

2. Transcriptome Analysis Reveals the Induction of Apoptosis-Related Genes by a Monoclonal Antibody against a New Epitope of CD99 on T-Acute Lymphoblastic Leukemia;Antibodies;2024-05-17

3. Stemness and Cell Cycle Regulators and Their Modulation by Retinoic Acid in Ewing Sarcoma;Current Issues in Molecular Biology;2024-04-26

4. Anti-CD99 Antibody Therapy Triggers Macrophage-Dependent Ewing Cell Death In Vitro and Myeloid Cell Recruitment In Vivo;Antibodies;2024-03-18

5. Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages;Cancer Immunology Research;2023-12-04